Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Development of a Pilot Program to Reduce Nitazoxanide Utilization at a Major Cancer Center in Patients with Discordant Norovirus Testing | Synapse
March 3, 2026
Development of a Pilot Program to Reduce Nitazoxanide Utilization at a Major Cancer Center in Patients with Discordant Norovirus Testing
GH
Guy Handley
The University of Texas MD Anderson Cancer Center
JB
Jovan Borjan
The University of Texas MD Anderson Cancer Center
NV
Nancy Vuong
Ver todo
Puntos clave
Reduced nitazoxanide use demonstrates effective intervention in clinicians' decision-making processes.
Utilization of nitazoxanide decreased by 30% over six months in patients receiving discordant norovirus testing.
Pilot program implementation involved targeted educational sessions and updated guidelines for clinicians.
Findings support the potential for similar programs in other cancer centers to improve treatment protocols.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Handley et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76050c6e9836116a2cedd
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.802